Medical device development, from conception to timely release to market, can be expensive and risky. This is particularly true for high-risk medical devices affected by the EU’s current Regulation 2017/745. Increasing med-tech companies’ chance of success in this process is the major goal of the TBMED project. To accomplish this, TBMED is establishing the Open Innovation Test Bed (OITB) go.Med. go.Med is the first OITB specifically designed to improve the innovation capacity of European small and medium-sized enterprises (SMEs).
A just-released video clip introduces viewers to the novel approach of TBMED and the benefits go.Med offers to SMEs and other interested parties in the highly competitive med-tech sector. The animated video highlights go.Med as a valuable acceleration platform that covers the entire development process for medical devices (from preclinical development to clinical testing). It shows the necessary steps in the journey towards developing a high-risk medical device, goes into detail on go.Med’s service portfolio, and shines a light on the innovative Quality-by-Design (QbD) concept that the TBMED OITB employs.